An observational study assessing the Safety and efficacy of Certolizumab pegol in patients with Psoriasis and Psoriatic Arthritis in real world setting
Latest Information Update: 18 Nov 2020
At a glance
- Drugs Certolizumab pegol (Primary)
- Indications Psoriasis; Psoriatic arthritis
- Focus Adverse reactions; Therapeutic Use
- 18 Nov 2020 New trial record
- 01 Nov 2020 Results published in the Journal of Dermatological Treatment